240 related articles for article (PubMed ID: 16940527)
21. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
22. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
23. Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.
Penninger JM; Timms E; Shahinian A; Jezo-Bremond A; Nishina H; Ionescu J; Hedrick SM; Mak TW
J Immunol; 1995 Oct; 155(8):3847-55. PubMed ID: 7561091
[TBL] [Abstract][Full Text] [Related]
24. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection.
Miyahira Y; Katae M; Kobayashi S; Takeuchi T; Fukuchi Y; Abe R; Okumura K; Yagita H; Aoki T
Infect Immun; 2003 Jun; 71(6):3131-7. PubMed ID: 12761091
[TBL] [Abstract][Full Text] [Related]
25. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
26. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
28. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Arens R; Flynn R; Sette A; Schoenberger SP; Croft M
J Immunol; 2009 Mar; 182(5):2909-18. PubMed ID: 19234186
[TBL] [Abstract][Full Text] [Related]
29. Codelivery of DNA coding for the soluble form of CD86 results in the down-regulation of the immune response to DNA vaccines.
Fló J; Tisminetzky S; Baralle F
Cell Immunol; 2001 May; 209(2):120-31. PubMed ID: 11446744
[TBL] [Abstract][Full Text] [Related]
30. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
[TBL] [Abstract][Full Text] [Related]
31. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
[TBL] [Abstract][Full Text] [Related]
32. CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.
Dias P; Giannoni F; Lee LN; Han D; Yoon S; Yagita H; Azuma M; Sarawar SR
J Virol; 2010 Aug; 84(16):8241-9. PubMed ID: 20534854
[TBL] [Abstract][Full Text] [Related]
33. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
34. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.
Eberlein J; Davenport B; Nguyen TT; Victorino F; Sparwasser T; Homann D
J Virol; 2012 Feb; 86(4):1955-70. PubMed ID: 22156513
[TBL] [Abstract][Full Text] [Related]
35. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.
Sugita S; Streilein JW
J Exp Med; 2003 Jul; 198(1):161-71. PubMed ID: 12835481
[TBL] [Abstract][Full Text] [Related]
36. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
37. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
[TBL] [Abstract][Full Text] [Related]
39. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
[TBL] [Abstract][Full Text] [Related]
40. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis.
Hattori H; Okano M; Yoshino T; Akagi T; Nakayama E; Saito C; Satoskar AR; Ogawa T; Azuma M; Nishizaki K
Clin Exp Allergy; 2001 Aug; 31(8):1242-9. PubMed ID: 11529894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
